850311C

DOCP

Avanti Polar Lipids 850311C

• 別名: 2-((2,3-bis(oleoyloxy)propyl)dimethylammonio)ethyl hydrogen phosphate
• 実験式（ヒル表記法）: C₄₃H₈₂NO₈P
• CAS番号: 1360461-57-9
• 分子量: 772.09
• UNSPSCコード: 51191904
• NACRES: NA.25

特性

• アッセイ: >99% (TLC)
• 形状: liquid
• 包装: pkg of 1 × 2.5 mL (850311C-25mg); pkg of 2 × 4 mL (850311C-200mg)
• メーカー／製品名: Avanti Polar Lipids 850311C
• 濃度: 10 mg/mL (850311C-25mg); 25 mg/mL (850311C-200mg)
• 脂質タイプ: cardiolipins; phospholipids
• 輸送温度: dry ice
• 保管温度: −20°C

詳細

詳細

DOCP is a zwitterionic /negatively charged lipid. It possess an inverse headgroup This synthetic molecule has stronger affinity than 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS).

Inverse-phosphocholine lipids, a remix of a common phospholipid, contain headgroups with an inverted charge orientation relative to phosphocholine (PC) lipids. The iPC lipid headgroup has a quaternary amine adjacent to the bilayer interface and a phosphate that extends into the aqueous phase. Therefore iPC lipids afford a unique opportunity to investigate the biophysical and bioactivity-related ramifications of a charge inversion at the bilayer surface.

アプリケーション

DOCP is suitable for use in the preparation of large unilamellar vesicles (LUVs) and in the preparation of liposomes.

包装

5 mL Clear Glass Sealed Ampule (850311C-200mg)

5 mL Clear Glass Sealed Ampule (850311C-25mg)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H302 - H315 - H319 - H331 - H336 - H351 - H361d - H372
• 注意書き: P202 - P301 + P312 - P302 + P352 - P304 + P340 + P311 - P305 + P351 + P338 - P308 + P313
• 危険有害性の分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
• ターゲットの組織: Respiratory system
• 保管分類コード: 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• 引火点(°F): does not flash
• 引火点(℃): does not flash